Cisplatin-based chemoradiotherapy vs. cetuximab-based bioradiotherapy for p16-positive oropharyngeal cancer: an updated meta-analysis including trials RTOG 1016 and De-ESCALaTE

Overview of attention for article published in European Archives of Oto-Rhino-Laryngology, March 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

policy: 1 policy source

twitter: 1 X user

Readers on

mendeley: 26 Mendeley

Summary Policy documents X

So far, Altmetric has seen 1 X post from an account with 1,432 followers.

p16陽性中咽頭癌に対するCDDP併用放射線治療とセツキシマブ併用放射線治療の比較。De-ESCALaTE含めたメタ解析が出てるな。Figure3みるとほぼ全ての研究でCDDP優位で2年生存のオッズ比は0.45（95%CI 0.31-0.65）と。あえてセツキシマブを選択しないだろうなあ。 https://t.co/y3NXtFJ7Cy

15 Apr 2019

Reply Repost Favourite